BPIQ Blog

Feb 22, 20233 min read

Upcoming Pegozafermin NASH Readout!

Summary: The upcoming readout from ETNB includes Phase 2b data from the pegozafermin trial in NASH. This is a Suspected Mover for Q1...

Jul 11, 20221 min read

(Posted 10am CST) $XBI $81.76 | -3.16% Table of Contents: Top 10 AM Positive Movers Top 10 AM Negative Movers Top 10 AM Volume Movers...

Jul 11, 20221 min read

(Posted 10am CST) $XBI $81.76 | -3.16% Table of Contents: Top 10 AM Positive Movers Top 10 AM Negative Movers Top 10 AM Volume Movers...

Our platform helps you uncover your next biotech investment opportunity